PharmacoEpidemiology and Drug Safety (PharmaSafe)
Medications are an essential aspect of health care. The PharmacoEpidemiology & Drug Safety Research Group (PharmaSafe) covers a wide range of research activities related to optimal use and safety of medication on an individual and societal level. We use epidemiological methods to address questions of drug safety that cannot be studied in randomized controlled trials (RCTs). Our work includes monitoring of drug utilization in pregnancy, perception towards medicines, methodology research, analysis of medication safety on patient outcomes and health economics.
The research group is multidiciplinary and has expertise in pharmacoepidemiology and drug safety, biostatistics, health economics and pharmacotherapy.
New article from PharmaTox summarises the research on prenatal medication exposure and offspring epigenetic outcomes
June 22, 2021 8:43 PM
A new literature review on genetic teratology from PharmaTox and the Federal University of Rio Grande do Sul
June 8, 2021 12:00 AM
New International Partnerships for Excellent Education, Research and Innovation (INTPART) project funded !
May 14, 2021 11:51 AM
The project is called "International Alliance for PharmacoGenetic Epidemiology Excellence (iAPOGEE)", and is led by Hedvig Nordeng, Department of Pharmacy.
What do we know about COVID-19 in pregnancy? And how has the pandemic impacted pregnancy and breast feeding women?
Apr. 26, 2021 4:07 PM
Prof. Hedvig Nordeng discussed this with Elise Koppang Frøjd who is pregnant in a special COVID-19.
Filling the knowledge gap: Which medications are used to treat COVID-19 in pregnancy
Apr. 26, 2021 3:58 PM
Prof. Nordeng is interviewed in Titan regarding COVID-19 research projects, use of health care registries across Europe and the need for knowledge on special populations like.